Independent large real-world study comparing NOACs in AF-patients
The results from an independent retrospective comparative study, published in January 2019 in the American Journal of Medicine, showed that dabigatran was associated with a more favourable benefit-harm profile than both warfarin and rivaroxaban. (Source: World Pharma News)
Source: World Pharma News - April 16, 2019 Category: Pharmaceuticals Tags: Featured Boehringer Ingelheim Business and Industry Source Type: news

Real-world-study-comparing-NOACs-in-AF-patients
Independent large real-world study comparing NOACs in AF-patientsA recently published large retrospective comparative study investigated stroke, bleeding and mortality risks in older US Medicare patients treated with commonly marketed oral anticoagulants for non-valvular atrial fibrillation1  Results of the real-world study showed that Pradaxa ® (dabigatran etexilate) was associated with a more favourable benefit-risk profile in comparison to both warfarin and rivaroxaban1Data from an earlier FDA-funded Medicare study published in 2015, which investigated cardiovascular, bleeding and mortality risks among patients...
Source: Boehringer Ingelheim Corporate News - April 15, 2019 Category: Research Source Type: news

FDA warns about risks of using home use test strips that are pre-owned or not authorized for sale in U.S., including those for glucose, warfarin
(Source: Food and Drug Administration)
Source: Food and Drug Administration - April 8, 2019 Category: American Health Source Type: news

Daily Aspirin No Longer Recommended To Prevent Heart Attacks In Older Adults
(CNN) — If you’re a healthy older adult looking for ways to reduce your risk of heart attack and stroke, don’t turn to that age-old standby: daily low-dose aspirin. It’s no longer recommended as a preventative for older adults who don’t have a high risk or existing heart disease, according to guidelines announced Sunday by the American College of Cardiology and the American Heart Association. “For the most part, we are now much better at treating risk factors such as hypertension, diabetes and especially high cholesterol,” said North Carolina cardiologist Dr. Kevin Campbell, who wa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 18, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news

XARELTO ® (rivaroxaban) Significantly Reduced the Risk of Overall Strokes and the Most Severe Strokes and Was Associated with Fewer Stroke-Related Deaths in the Real World Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation
(Source: Johnson and Johnson)
Source: Johnson and Johnson - March 18, 2019 Category: Pharmaceuticals Source Type: news

Direct Oral Anticoagulants of Benefit in Afib With Mitral Stenosis (CME/CE)
(MedPage Today) -- DOACs linked with lower rates of thromboembolism than warfarin and just as effective in preventing hemorrhagic strokes (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - March 17, 2019 Category: Urology & Nephrology Source Type: news

AUGUSTUS Backs Apixaban'Double Therapy' in Most AF Post-ACS, PCI AUGUSTUS Backs Apixaban'Double Therapy' in Most AF Post-ACS, PCI
The most safe and effective antithrombotic regimen may involve neither warfarin nor aspirin, suggested a trial that might allay bleeding-risk concerns in a tough-to-treat atrial fibrillation population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 17, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

DOACs Promising for Afib Patients With Mitral Stenosis
(MedPage Today) -- Warfarin not necessarily the go-to therapy, Korean study finds (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 11, 2019 Category: Cardiology Source Type: news

Doubling up on blood thinners increases risk for excessive bleeding
Patients who use an anticoagulant such as warfarin should be careful if they are also on an aspirin regimen as it can increase the risk for excessive bleeding, a new study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 4, 2019 Category: Consumer Health News Source Type: news

Another medication more dangerous than the condition it treats: Blood-thinning drugs increase risk of internal bleeding, death
(Natural News) Using antithrombotic or blood-thinning medications was found to increase the risk of hematuria, or the presence of blood in urine, and other related complications. A study published in the Journal of the American Medical Association (JAMA) found that antithrombotic medications such as warfarin and aspirin may cause adverse health events. The study involved 2,518,064... (Source: NaturalNews.com)
Source: NaturalNews.com - February 14, 2019 Category: Consumer Health News Source Type: news

Medical News Today: What to know about the warfarin diet
Warfarin is a blood thinner that can be more effective when restricting foods that are vitamin K-rich. Examples of these include broccoli and asparagus. Learn more about foods to avoid on the warfarin diet here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 12, 2019 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

FDA doubles down on warfarin test strip recall
The FDA this week alerted patients and doctors about test strips used to monitor levels of the blood thinner warfarin, expanding and reiterating its warning that the products shouldn’t be used to adjust a person’s drug dosage. The agency’s latest notice is related to the Class I recall of Roche‘s CoaguChek meters and test strips, which the FDA issued in November last year. The initial recall involved more than 1.1 million packages of CoaguChek XS PT test strips that were distributed across the U.S. from Jan. 12 – Oct. 29 of 2018. Get the full story at our sister site, Drug Deliv...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Diagnostics Featured Pharmaceuticals Recalls Regulatory/Compliance Vascular Roche Diagnostics Source Type: news

Expanded Recall of Warfarin Level Monitoring Test Strips
MONDAY, Feb. 4, 2019 -- Certain lots of Roche Diagnostics test strips should not be used with CoaguChek test meter devices to check levels of the blood thinner warfarin because patients may get inaccurate results and be at risk for serious injury or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 4, 2019 Category: Pharmaceuticals Source Type: news

On February 1st, @US_FDA classified a Class I Recall, the most serious type of recall: Terrific Care, LLC. / Medex Supply Recalls CoaguChek XS PT Test Strips Used to Monitor Blood Thinner Warfarin Due to Inaccurate Test Results. Find out more here: https://go.usa.gov/xEX7Y   pic.twitter.com/MeFubksqsa
On February 1st, @US_FDA classified a Class I Recall, the most serious type of recall: Terrific Care, LLC. / Medex Supply Recalls CoaguChek XS PT Test Strips Used to Monitor Blood Thinner Warfarin Due to Inaccurate Test Results. Find out more here: https://go.usa.gov/xEX7Y  pic.twitter.com/MeFubksqsa (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - February 4, 2019 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Health Highlights: Feb. 4, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Recall Expanded for Warfarin Test Strips Certain lots of Roche Diagnostics test strips should not be used with CoaguChek test meter devices to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 4, 2019 Category: General Medicine Source Type: news

FDA warns patients and doctors about recall of home-use test strips used with device to monitor blood thinner warfarin, not authorized for sale in U.S.
Medical product distributor issued voluntary recall of certain Roche Diagnostics test strips used with CoaguChek test meter devices. (Source: Food and Drug Administration)
Source: Food and Drug Administration - February 1, 2019 Category: American Health Source Type: news

Direct oral anticoagulants reduce costs compared with warfarin
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2019 Category: Drugs & Pharmacology Source Type: news

AF Guideline Update Prefers NOACs to Warfarin in Most Cases AF Guideline Update Prefers NOACs to Warfarin in Most Cases
More nuanced use of stroke-risk scores, percutaneous LAA occlusion, insights into AF complicating ACS, and ascendant non-vitamin-K oral anticoagulants top an AHA/ACC/HRS update to 2014 AF guidelines.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

New blood thinners better than warfarin for atrial fibrillation
(Reuters Health) - Patients with atrial fibrillation, a common heart rhythm disorder, should take newer blood thinners to prevent stroke instead of the old standby drug warfarin, U.S. doctors recommend. (Source: Reuters: Health)
Source: Reuters: Health - January 29, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

NOACs Recommended as First-Line Prevention of Stroke in A-Fib
TUESDAY, Jan. 29, 2019 -- For patients with atrial fibrillation, novel oral anticoagulants (NOACs) are recommended over warfarin to prevent stroke and weight loss is recommended for overweight and obese individuals, according to updated guidelines... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2019 Category: Pharmaceuticals Source Type: news

New AFib Guidelines Advocate NOACs Over Warfarin
(MedPage Today) -- Weight loss also promoted for stroke prevention in atrial fibrillation (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 28, 2019 Category: American Health Source Type: news

Warfarin no longer recommended for most atrial fibrillation cases
The anti-clotting drug warfarin, commonly known as coumadin, is no longer recommended for the treatment of atrial fibrillation except for a select subset of patients, according to new guidelines just released by the American College of Cardiology and the American Heart Association. (Source: CNN.com - Health)
Source: CNN.com - Health - January 28, 2019 Category: Consumer Health News Source Type: news

Cardiologist Groups Say Newer Blood Thinners Best Against A-Fib
MONDAY, Jan. 28, 2019 -- Newer blood thinners are recommended over warfarin for people with the heart condition called atrial fibrillation (a-fib) in updated treatment guidelines issued by three major American heart groups. The newer drugs are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 28, 2019 Category: General Medicine Source Type: news

Aspirin vs. warfarin (Coumadin, Jantoven)
Title: Aspirin vs. warfarin (Coumadin, Jantoven)Category: MedicationsCreated: 1/28/2019 12:00:00 AMLast Editorial Review: 1/28/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - January 28, 2019 Category: Drugs & Pharmacology Source Type: news

Higher Incidence of Ischemic Stroke in Patients Taking NOACs Higher Incidence of Ischemic Stroke in Patients Taking NOACs
Does the reduced risk of nontraumatic bleeding in patients taking NOACs as opposed to warfarin come at the cost of a higher risk of ischemic stroke?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 17, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Statins are being overprescribed, study suggests
The risks of statins for primary prevention are greater than the benefits for many patients Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Direct oral anticoagulants as safe as warfarin after VTE Too few women take part in many CVD clinical trials Use of DPP-4 inhibitors associated with increased risk of IBD Metformin doesn ’t help HbA1c in teens with type 1 diabetes (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 4, 2018 Category: UK Health Source Type: news

Barriers to using stroke-preventing anticoagulants in Canada hinder appropriate management of patients with atrial fibrillation
(Elsevier) International guidelines recommend direct oral anticoagulants (DOACs) over warfarin to prevent stroke for most patients with atrial fibrillation (AF). However, a substantial portion of patients in Canada, who would benefit from anticoagulation, do not receive it adequately or at all. Experts review the evidence for the use of DOACs in the Canadian Journal of Cardiology, discuss reasons for the large gap between guidelines and clinical practice, including policy and funding barriers, and propose strategies for the future. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 5, 2018 Category: International Medicine & Public Health Source Type: news

FDA issues Class I recall for Roche Diagnostics ’ warfarin test strips
The FDA today issued a Class I recall for certain lots of Roche Diagnostics‘ warfarin test strips used with the CoaguCheck test meter devices. Roche voluntarily recalled the strips in September, warning that for patients and doctors who use at-home devices to monitor levels of the blood thinner, the devices may yield inaccurate results. The FDA said today that the devices should not be used to adjust drug dosages. Get the full story at our sister site, Drug Delivery Business News. The post FDA issues Class I recall for Roche Diagnostics’ warfarin test strips appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diagnostics Food & Drug Administration (FDA) Pharmaceuticals Recalls Regulatory/Compliance Vascular Wall Street Beat Roche Diagnostics Source Type: news

FDA recalls devices over inaccurate warfarin test results
The Food and Drug Administration announced a recall of test strips that monitor levels of the blood thinner wafarin may give inaccurate results. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 2, 2018 Category: Consumer Health News Source Type: news

FDA recalls test strips over inaccurate warfarin test results
The Food and Drug Administration has announced a recall of test strips that monitor levels of the blood thinner warfarin because they may give inaccurate results. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 2, 2018 Category: Consumer Health News Source Type: news

Warfarin INR Test Strips Recalled
(MedPage Today) -- Class I recall for over 1.1 million packages of CoaguChek XS PT strips (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 2, 2018 Category: American Health Source Type: news

FDA: Class I Recall of Roche Warfarin INR Test Strips FDA: Class I Recall of Roche Warfarin INR Test Strips
The problematic strips, used with CoaguChek anticoagulation meters, could lead to warfarin doses that are too low. Roche says it is issuing properly functioning replacements.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

FDA warns patients and doctors about risk of inaccurate results from home-use device to monitor blood thinner warfarin
Roche Diagnostics issued voluntary recall of certain test strips used with CoaguChek meter devices; patients affected by the recall should seek alternative methods for testing. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 1, 2018 Category: American Health Source Type: news

Dabigatran, Rivaroxaban, Warfarin in Oldest Adults With AF Dabigatran, Rivaroxaban, Warfarin in Oldest Adults With AF
This study compared the effectiveness and safety of reduced-dose dabigatran, reduced-dose rivaroxaban, and warfarin in individuals aged 85 and older with atrial fibrillation.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Impact of a 4F-PCC Protocol in Warfarin-Associated ICH Impact of a 4F-PCC Protocol in Warfarin-Associated ICH
A pharmacist-driven 4F-PCC protocol for warfarin-associated intracranial hemorrhage may help reduce time to administration.Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2018 Category: Consumer Health News Tags: Emergency Medicine Journal Article Source Type: news

NOACs for Mechanical Heart Valves: Is the Door Still Open? NOACs for Mechanical Heart Valves: Is the Door Still Open?
Currently, NOACs are contraindicated in patients with mechanical heart valves based on the results of a single study comparing dabigatran and warfarin. Does this need to be re-evaluated?Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 22, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Air pollution link to heightened mouth cancer risk
High levels of fine particulate matter seem key Related items fromOnMedica Lower cancer risk in people with higher vitamin D levels Global cancer burden set to soar Cancer survival rates not improved much in a decade Warfarin is not the answer for thromboses in cancer patients The NHS must adapt now to care for older cancer patients (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 10, 2018 Category: UK Health Source Type: news

Meta-Analysis: Oral Anticoagulant Choice Matters in Afib Cardioversion
(MedPage Today) -- DOACs may be better than warfarin at preventing thromboembolic events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 8, 2018 Category: Cardiology Source Type: news

Net Benefit of Anticoagulants for A - Fib Varies With Stroke Rate
Benefit of warfarin anticoagulation varies with varying published stroke rates (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 25, 2018 Category: Cancer & Oncology Tags: Cardiology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Anticoagulation on Warfarin Weakens After 6 Months
(MedPage Today) -- But patients hitting TTR target still had fewer events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 12, 2018 Category: Cardiology Source Type: news

Anticoagulation Control on Warfarin Weakens After 6 Months
(MedPage Today) -- But patients hitting TTR target still had fewer events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 12, 2018 Category: Cardiology Source Type: news

Switching from warfarin reduces healthcare  use and costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Apixaban for AF in ESRD: Fewer Strokes, Major Bleeds vs Warfarin Apixaban for AF in ESRD: Fewer Strokes, Major Bleeds vs Warfarin
' I think this is the best data we have so far'supporting the use of apixaban in the especially high-risk population with atrial fibrillation, the lead researcher concludes. A randomized trial is forthcoming.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 31, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

More Bleeding on NOACs Seen in Kidney Disease? (CME/CE)
(MedPage Today) -- Stroke prevention similar to warfarin in observational study (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 12, 2018 Category: Primary Care Source Type: news

Apixaban Is Safest Direct Oral Anticoagulant Versus Warfarin
Reduced risks of major, intracranial, and gastrointestinal bleeding compared with warfarin (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 11, 2018 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Gastroenterology, Internal Medicine, Neurology, Oncology, Pharmacy, Journal, Source Type: news

Apixaban Is Safest Direct Oral Anticoagulant Versus Warfarin
WEDNESDAY, July 11, 2018 -- Apixaban seems to be the safest direct oral anticoagulant (DOAC) compared with warfarin, according to a study published July 4 in The BMJ. Yana Vinogradova, Ph.D., from the University of Nottingham in the United Kingdom,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 11, 2018 Category: Pharmaceuticals Source Type: news

HPV Versus Pap; DOACs and Warfarin: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include DOACs and warfarin, use of defibrillators after Department of Justice involvement, HPV testing versus Pap smears, and interfering with RNA in a genetic disease (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 7, 2018 Category: Cardiology Source Type: news

Cheap drug hope for 500,000 at risk of stroke
HALF a million Britons who are unknowingly at risk of a fatal stroke caused by an irregular heartbeat could be saved by cheap clot-busting drugs, according to research. A study in the European Heart Journal found that 4,000 strokes were prevented in England between 2015 and 2016 among patients with atrial fibrillation , a heart rhythm disorder, by taking anti-coagulants such as warfarin. (Source: Daily Express - Health)
Source: Daily Express - Health - July 6, 2018 Category: Consumer Health News Source Type: news

New blood-thinning drugs 'could be far safer than the commonly-prescribed warfarin'  
The study – published in the British Medical Journal – looked at 196,061 patients taking blood thinning drugs between 2011 and 2016 who were taking warfarin or the newer type drug. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news

Study Highlights Benefits of Newer Anticoagulants Study Highlights Benefits of Newer Anticoagulants
Newer oral anticoagulants, especially apixaban, are associated with a lower risk of major bleeds versus warfarin in patients with and without atrial fibrillation, a large UK study reveals.Medscape News UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news